Collagen crosslink excretion and staging of oral cancer

British Journal of Cancer

Volumn 88, Issue 7, 2003, Pages 1105-1110

  Springer, I N G ^a   Terheyden, H ^a   Dunsche, A ^a   Czech, N ^a   Suhr, M A A ^b   Tiemann, M ^a   Hedderich, J ^a   Acil Y ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Klinikum Nord   (Germany)

Author keywords

Bone infiltration; Collagen crosslinks; Oral squamous cell carcinoma; Pyridinoline; Staging

Indexed keywords

COLLAGEN DERIVATIVE; DEOXYPYRIDINOLINE; PYRIDINOLINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CROSS LINKING; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANDIBLE; MOUTH CARCINOMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; URINALYSIS; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; CARCINOMA, SQUAMOUS CELL; COLLAGEN; HUMANS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING;

EID: 0038368910     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600873     Document Type: Article

References (33)

1. Acil Y, Brinckmann J, Notbohm H, Muller PK, Batge B (1996) Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). Scand J Clin Lab Invest 56: 275-283
2. Acil Y, Müller PK (1994) A rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). J Chromatogr A 664: 183-188
3. Acil Y, Terheyden H, Dunsche A, Fleiner B, Jepsen S (2000) Three-dimensional cultivation of human osteoblast-like cells on highly porous natural bone mineral. J Biomed Mater Res 51: 703-710
4. Acil Y, Vetter U, Brenner R, Muller PK, Brinckmann J (1995) Ehlers-Danlos syndrome type VI: cross-link pattern in tissue and urine sample as a diagnostic marker. J Am Acad Dermatol 33: 522-524
5. Baker A, McMahon J, Parmar S (2001) Immediate reconstruction of continuity defects of the mandible after tumor surgery. J Oral Maxillofac Surg 59: 1333-1339
6. Body JJ, Delmas PD (1992) Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia. J Clin Endocrinol Metab 74: 471-475
7. Chen JT, Hosoda K, Hasumi K, Ogata E, Shiraki M (1996) Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J Bone Miner Res 11: 1784-1792
8. Coleman RE, Purohit OP, Black C, Vinholes JJ, Schlosser K, Huss H, Quinn KJ, Kanis J (1999) Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease. Ann Oncol 10: 311-316
9. Coleman RE, Purohit OP, Vinholes JJ, Zekri J (1997) High dose pamidronate: clinical and biochemical effects in metastatic bone disease. Cancer 80: 1686-1690
10. Demers LM, Costa L, Lipton A (2000) Biochemical markers and skeletal metastases. Cancer 88: 2919-2926
11. Eyre D (1992) New biomarkers of bone resorption. J Clin Endocrinol Metab 74: 470A-470C
12. Fontana A, Delmas PD (2000) Markers of bone turnover in bone metastases. Cancer 88: 2952-2960
13. Hong SX, Cha IH, Lee EW, Kim J (2001) Mandibular invasion of lower gingival carcinoma in the molar region: its clinical implications on the surgical management. Int J Oral Maxillofac Surg 30: 130-138
14. Huntley TA, Busmanis I, Desmond P, Wiesenfeld D (1996) Mandibular invasion by squamous cell carcinoma: a computed tomographic and histological study. Br J Oral Maxillofac Surg 34: 69-74
15. Izumi M, Nakanishi Y, Takayama K, Kimotsuki K, Inoue K, Wataya H, Minami T, Hara N (2001) Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma. Cancer 91: 1487-1493
16. Liubimova NV, Bronnikov II, Robins SP, Trapeznikova MF, Kushlinskii NE (2000) The biochemical markers of bone remodeling in cancer patients with skeletal involvement. Vopr Onkol 46: 290-297
17. Marttunen MB, Hietanen P, Titinen A, Roth HJ, Viinikka L, Ylikorkala O (1999) Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer. Calcif Tissue Int 65: 365-368
18. Minn H, Aitasalo K, Happonen RP (1993) Detection of cancer recurrence in irradiated mandible using positron emission tomography. Eur Arch Otorhinolaryngol 250: 312-315
19. Miyamoto KK, McSherry SA, Robins SP, Besterman JM, Mohler JL (1994) Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma. J Urol 151: 909-913
20. Papatheofanis FJ (1997) Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma. J Nucl Med 58: 1175-1179
21. Pecherstorfer M, Zimmer-Roth I, Schilling T, Woitge HW, Schmidt H, Baumgartner G, Thiebaud D, Ludwig H, Seibel MJ (1995) The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. J Clin Endocrinol Metab 80: 97-103
22. Reichart PA, Philipsen HP (1999) Maligne tumoren. In Oralpathologie, Rateitschak KH, Wolf HF (eds) pp 108-118. Farbadanten der Zahnmedizin. Thieme: Stuttgart
23. Schimmele SR (2001) Delayed reconstruction of continuity defects of the mandible after tumor surgery. J Oral Maxillofac Surg 59: 1340-1344
24. Schimming R, Juengling FD, Altehofer C, Schmelzeisen R (2001) Diagnosis of questionable mandibular infiltration by squamous epithelial carcinomas. 3-D 99mTc-DPD SPECT reconstruction and (18F) fluoride PET study: diagnostic advantages or unnecessary expense? HNO 49: 355-360
25. Stone PJ, Bryan-Rhadfi J, Shaw HA, Franzblau C (1992) Isolation of hydroxylysyl pyridinoline, a mature collagen crosslink from neonatal rat aorta smooth muscle cell cultures. Matrix 12: 381-387
26. Takeuchi S, Arai K, Saitoh H, Yoshida K, Miura M (1996) Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer. J Urol 156: 1691-1695
27. Tamada T, Sone T, Tomomitsu T, Jo Y, Tanaka H, Fukunaga M (2001) Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy. J Bone Miner Metab 19: 45-51
28. Tamura H, Ishii S, Ikeda T, Enomoto K, Kitajima M (1999) The relationship between urinary pyridinoline, deoxypyridinoline and bone metastasis in a rat breast cancer model. Breast Cancer 6: 23-28
29. Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE (1996) Metabolic effects of pamidronate in patients with metastatic bone disease. Br J Cancer 73: 1089-1095
30. Walne AJ, Jenkins PJ, James IT, Plowman PN (1997) Pyridinium crosslinks in the monitoring of patients with bone metastases from carcinoma of the breast. Clin Oncol 9: 30-34
31. Woitge HW, Pecherstorfer M, Horn E, Keck AV, Diel IJ, Bayer P, Ludwig H, Ziegler R, Seibel MJ (2001) Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. Br J Cancer 84: 344-351
32. Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, Seibel MJ (1999) Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res 14: 792-801
33. Yoshida K, Sumi S, Arai K, Koga F, Umeda H, Hosoya Y, Honda M, Yano M, Moriguchi H, Kitahara S (1997) Serum concentration of type I collagen metabolites as a quantitative marker of bone metastases in patients with prostate carcinoma. Cancer 80: 1760-1767